NCT00195416View on ClinicalTrials.gov

Study Investigating Enbrel Treatment for Ankylosing Spondylitis

CompletedOBSERVATIONAL
Enrollment

526

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Etanercept

Etanercept 25mg Injection, 2 times/week

Trial Locations (3)

463-707

Gyunggi-do

140-575

Seoul

143-914

Seoul

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195416 - Study Investigating Enbrel Treatment for Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter